tradingkey.logo
搜索

InMed Pharmaceuticals Inc

INM
添加自选
1.460USD
-0.040-2.67%
收盘 07-31 16:00美东报价延迟15分钟
4.09M总市值
亏损市盈率 TTM

INM 财务数据

通过专为投资者打造的一站式数据看板,全面查看 InMed Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

InMed Pharmaceuticals Inc财报日历

最新发布
5月 6, 2026
每股收益 / 预测值
--/--
营业收入 / 预测值
--/--
报告期
FY2025 财报
营业收入(YoY)
4.94M
7.50%
每股收益(YoY)
-8.36
58.48%
分析师评级
--
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
财务指标
每股收益
62.14%-0.73
85.93%-0.51
99.19%-0.44
70.32%-1.20
46.01%-1.94
1.71%-3.64
-254.97%-54.11
-98.36%-4.04
70.15%-3.58
79.70%-3.71
81.20%-15.24
---2.04
---12.01
---18.27
---81.10
----
----
----
----
----
营业收入
----
-26.22%820.19K
-11.43%1.12M
1.69%1.30M
7.59%1.26M
-10.36%1.11M
40.23%1.26M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
348.96%2.31M
233.97%1.03M
77.22%469.78K
--320.79K
--514.76K
--309.58K
--265.09K
----
----
净利润
-39.86%-2.97M
21.23%-2.03M
-2.92%-1.73M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
95.70%-338.39K
42.52%-2.00M
50.94%-2.10M
-18.12%-3.51M
-141.50%-7.87M
-12.06%-3.48M
-90.87%-4.28M
-85.83%-2.97M
-101.62%-3.26M
利润率
----
-6.76%-247.29%
-16.20%-154.17%
9.24%-137.07%
-14.42%-168.12%
-94.34%-231.63%
52.83%-132.68%
-931.39%-151.02%
23.97%-146.93%
73.35%-119.19%
74.29%-281.29%
---14.64%
---193.24%
---447.25%
---1094.24%
----
----
----
----
----
毛利率
----
-56.45%15.97%
2.82%31.24%
25.26%40.15%
-71.88%5.63%
69.13%36.67%
915.80%30.38%
-51.16%32.06%
45.91%20.01%
24.05%21.68%
97.79%-3.72%
--65.64%
--13.72%
--17.48%
---168.36%
----
----
----
----
----
营业收入
----
-26.22%820.19K
-11.43%1.12M
1.69%1.30M
7.59%1.26M
-10.36%1.11M
40.23%1.26M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
348.96%2.31M
233.97%1.03M
77.22%469.78K
--320.79K
--514.76K
--309.58K
--265.09K
----
----
营业利润
-33.14%-2.82M
3.88%-2.12M
-0.54%-1.76M
8.31%-1.84M
-17.77%-2.12M
-29.41%-2.21M
33.16%-1.75M
-289.14%-2.01M
16.43%-1.80M
23.69%-1.70M
24.57%-2.62M
83.06%-516.26K
39.28%-2.15M
45.67%-2.23M
-20.28%-3.48M
7.83%-3.05M
-12.95%-3.54M
-112.59%-4.11M
-84.96%-2.89M
-111.93%-3.31M
净利润
-39.86%-2.97M
21.23%-2.03M
-2.92%-1.73M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
95.70%-338.39K
42.52%-2.00M
50.94%-2.10M
-18.12%-3.51M
-141.50%-7.87M
-12.06%-3.48M
-90.87%-4.28M
-85.83%-2.97M
-101.62%-3.26M
流动资产
7.46%6.89M
60.67%8.79M
48.35%10.80M
48.08%12.87M
-36.31%6.41M
-53.68%5.47M
-12.24%7.28M
-23.32%8.69M
-15.02%10.06M
-15.75%11.81M
-28.14%8.30M
18.07%11.33M
35.39%11.84M
12.10%14.02M
-27.75%11.54M
14.56%9.60M
-19.73%8.75M
22.01%12.51M
--15.98M
32.73%8.38M
流动负债总额
20.25%2.21M
-17.36%1.48M
8.29%1.55M
-6.70%1.84M
20.29%1.84M
6.57%1.79M
7.22%1.44M
-1.44%1.97M
-32.64%1.53M
-30.00%1.68M
-59.19%1.34M
-39.73%2.00M
-44.72%2.27M
-48.01%2.40M
70.32%3.28M
49.84%3.32M
139.49%4.11M
114.42%4.62M
--1.93M
32.16%2.22M
总资产
-1.57%9.13M
31.63%11.19M
27.67%13.36M
31.78%15.58M
-30.53%9.28M
-44.27%8.50M
-4.14%10.47M
-16.19%11.82M
-9.31%13.36M
-9.84%15.26M
-25.14%10.92M
10.31%14.11M
-4.88%14.73M
-12.71%16.92M
-15.83%14.58M
30.74%12.79M
25.44%15.49M
65.00%19.38M
--17.33M
25.36%9.78M
总负债
-0.72%2.24M
-30.88%1.60M
-14.46%1.77M
-18.00%2.15M
0.19%2.26M
-6.57%2.32M
54.54%2.07M
29.76%2.62M
-3.77%2.25M
-3.92%2.48M
-62.55%1.34M
-45.63%2.02M
-49.07%2.34M
-50.45%2.58M
69.85%3.58M
54.24%3.71M
138.23%4.60M
25.50%5.22M
--2.11M
24.96%2.40M
总权益
-1.85%6.89M
55.09%9.59M
38.06%11.59M
45.93%13.43M
-36.77%7.02M
-51.60%6.18M
-12.35%8.40M
-23.85%9.21M
-10.36%11.10M
-10.90%12.77M
-12.99%9.58M
33.17%12.09M
13.79%12.39M
1.18%14.34M
-27.68%11.01M
23.07%9.08M
4.53%10.89M
86.64%14.17M
--15.22M
25.49%7.38M
经营净额
-82.14%-3.02M
5.03%-2.38M
12.00%-1.61M
-72.81%-1.78M
14.21%-1.66M
-35.39%-2.50M
15.98%-1.83M
-56.42%-1.03M
-16.76%-1.93M
31.88%-1.85M
3.61%-2.17M
83.74%-657.93K
69.03%-1.66M
23.22%-2.71M
15.01%-2.26M
-101.75%-4.05M
-15.99%-5.35M
---3.53M
-93.49%-2.65M
-43.43%-2.01M
投资净额
--0.00
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
--0.00
100.00%0.00
100.00%-2.00
98.14%-9.29K
--0.00
95.37%-33.61K
-3508.16%-128.20K
-263.39%-500.00K
100.00%0.00
-41955.48%-725.46K
---3.55K
--306.01K
---250.00K
-287.91%-1.73K
融资净额
-92.07%231.68K
-100.00%0.00
-116.37%-137.18K
4644531.25%8.17M
--2.92M
-92.73%338.52K
--838.24K
--176.00
100.00%0.00
-12.44%4.65M
-100.00%0.00
-100.00%0.00
-117.31%-63.70K
735.69%5.32M
-50.12%5.43M
6172.97%5.05M
-100.72%-29.31K
---836.14K
16936.86%10.88M
-168.37%-83.18K

常见问题

InMed Pharmaceuticals Inc的总收入是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,总收入达到了4.94M(同比变化4.60M)。

InMed Pharmaceuticals Inc的流动资产是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,流动资产为12.87M(同比变化48.08)。

InMed Pharmaceuticals Inc的总资产是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,InMed Pharmaceuticals Inc的总资产为15.58M(同比变化31.78)。

InMed Pharmaceuticals Inc的总负债是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,InMed Pharmaceuticals Inc的总负债为2.15M(同比变化-18.00)。

InMed Pharmaceuticals Inc的总权益是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,InMed Pharmaceuticals Inc的总权益为13.43M(同比变化45.93)。

InMed Pharmaceuticals Inc的净营业收入是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,InMed Pharmaceuticals Inc的净营业收入为-7.92M(同比变化2.66)。

InMed Pharmaceuticals Inc的净融资是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,InMed Pharmaceuticals Inc的净融资为12.27M(同比变化163.66)。

InMed Pharmaceuticals Inc的每股收益(EPS)是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-8.36(同比变化58.48)。

InMed Pharmaceuticals Inc的净利润是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,净利润为-8.16M(同比变化-6.34)。

InMed Pharmaceuticals Inc的净利润率是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,净利润率为-165.14(同比变化1.08)。

InMed Pharmaceuticals Inc的毛利率是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,毛利率为30.22(同比变化57.66)。

InMed Pharmaceuticals Inc的股东权益回报率(ROE)是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-72.10(同比变化-0.02)。

InMed Pharmaceuticals Inc的资产回报率(ROA)是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-59.57(同比变化-0.62)。

InMed Pharmaceuticals Inc的营业利润是多少?

根据InMed Pharmaceuticals Inc的FY2025财报,营业利润为-7.92M(同比变化2.66)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有